ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,784,708 | -15.8% | 765,833 | -4.6% | 0.64% | -6.9% |
| Q2 2023 | $24,688,730 | -23.3% | 803,167 | -10.1% | 0.69% | -22.9% |
| Q1 2023 | $32,181,363 | -21.0% | 893,192 | -13.4% | 0.90% | -18.1% |
| Q4 2022 | $40,754,574 | -5.5% | 1,031,269 | -4.0% | 1.10% | -14.6% |
| Q3 2022 | $43,143,000 | -47.8% | 1,073,745 | -45.4% | 1.28% | -6.8% |
| Q2 2022 | $82,623,000 | +2.1% | 1,965,336 | -5.4% | 1.38% | +25.6% |
| Q1 2022 | $80,908,000 | -9.5% | 2,076,728 | -7.4% | 1.10% | -0.8% |
| Q4 2021 | $89,357,000 | – | 2,242,330 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |